ACIDE ALENDRONIQUE ALTER 70 mg, film-coated tablet 4 tablets
Active ingredients: Alendronic acid, Alendronate sodium trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACIDE ALENDRONIQUE ALTER 70 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 4 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES ALTER
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Nov 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69784280CIP73824983CIP133400938249835Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALENDRONATE MONOSODIQUE TRIHYDRATÉcomprimé | 91,350 mg · un comprimé | SA |
| ACIDE ALENDRONIQUEcomprimé | 70,000 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.